PATENT CLAIM ANALYSIS

Application Number: 15911535
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-12
Patent Classification: ["514", "304000"]

Abstract:
The invention relates to (hetero)aryl cyclopropylamine compounds, including particularly the compounds of formula I as described and defined herein, and their use in therapy, including, e.g., in the treatment or prevention of cancer, a neurological disease or condition, or a viral infection.

Claim (Index 381):
The method of  claim 380 , wherein said compound is N-((1R,2S)-2-(2-fluorophenyl)cyclopropyl)piperidin-4-amine, or a pharmaceutically acceptable salt or solvate thereof.

Metadata:
- Claim Count in Document: 59.0
- Percentile: 90.0
- Lexical Diversity: 1.39474
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15271772', '15254020', '14352719', '14352711', '15497556']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7978232397054538
- 35 USC 102 Novelty (BERT): 0.5573431486424804
- Combined Prediction Score: 0.7737752305991564
- Mean Citation Score: 402.807258
- Max Citation Score: 440.12256
- Similarity Product: 337.23295235618593

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test